ST.-LAURENT, Quebec (AP) _ Nymox Pharmaceutical Corp. (NYMX) on Tuesday reported a loss of $2.7 million in its first quarter.
On a per-share basis, the St.-Laurent, Quebec-based company said it had a loss of 5 cents.
The biopharmaceutical company posted revenue of $152,000 in the period.
The company's shares closed at $3.92. A year ago, they were trading at $3.99.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NYMX at https://www.zacks.com/ap/NYMX